INTELLIGENCE IN ACTION

Patients Are Ready to Talk Dollars with Their Doctors

February 18, 2020

The era of patients as mere passengers on their healthcare journey is over.

With more skin in the game than ever before, patients are becoming savvy, engaged and discerning consumers. They know that the name-brand drug with the $300 monthly price tag may not be the only option. They want a healthcare provider who has the information needed to compare and guide them to alternatives that achieve the same or similar outcome.

Most patients who skip a medication due to cost say they would have been willing to take a lower-cost alternative if their doctor or nurse had suggested one. This is the definition of a missed opportunity. And many are willing to switch healthcare providers in order to have cost conversations at the point of care.

These and other insights from our recent survey, Prescription Price Transparency and the Patient Experience, show greater demand among patients for cost conversations with healthcare providers at the point of care.

Here are a few highlights:

  • More than half of patients had not taken a medication because it cost too much.
  • Of those who skipped a medication due to cost, 94% would have been willing to take a lower-cost alternative if their doctor or nurse had suggested one.
  • Nearly 70% of millennials say the ability to talk with their provider about prescription cost has a moderate or significant impact on which doctor they choose, compared with 51% of middle-aged patients and 32% of Medicare-age patients.
  • Nearly one-third of (28%) of millennials would be willing to find a new doctor in order to have cost conversations about their prescriptions.

Download the full report to better understand how patients feel about talking to their healthcare providers about the cost of their medications. And learn more about solutions that address these needs from patients and deliver prescription price transparency to the point of care.

Related Articles

April 28, 2020

5 Questions: Michelle Trombetta on Improving the Patient Experience and the Power of Vulnerability

While Michelle Trombetta has held many different titles in product, technology, and operations, and had the opportunity to work across the globe, one thing has been consistent, and that’s her desire to make a positive impact on the world around her.  Read more...
March 04, 2020

Prescription Price Transparency: Good for Patients, Good for Health Plans

Receiving a diagnosis at a routine doctor’s appointment can be incredibly scary, even for something as treatable as type 2 diabetes. But the right price transparency tools—or lack thereof—can make (or break) that experience for a patient.  Read more...
February 25, 2020

Price Transparency: It’s in the Best Interest of Patients and Providers

“In all my years in health IT this is one of the most exciting and most rapidly adopted clinical decision support tools I’ve ever been associated with,” said Andrew Mellin, MD and vice president of Medical Informatics at Surescripts, referring to Surescripts’ prescription price transparency tool Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX